Arcutis Biotherapeutics Inc (ARQT) Earning Prediction
Arcutis Biotherapeutics Inc (ARQT) is set to release its earnings performance on 02/25 ET in After Hours trading. Consensus forecasts predict a revenue of 115.71M and an earnings per share (EPS) of 0.03 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
ARQT Transcript
The earnings call summary indicates a positive sentiment due to a 20% revenue increase and a 10% improvement in net loss, suggesting strong product sales and cost efficiency. Although cash reserves decreased, this was due to strategic investments. The lack of explicit or implied risks and the absence of concerning Q&A responses further support a positive outlook. Given the small-cap status, the stock price is likely to react positively, falling within the 2% to 8% range.
The earnings call summary and Q&A provide a positive outlook. The company reported strong financial metrics, including a 28% QoQ sales growth and positive cash flow. ZORYVE's market expansion and upcoming approvals suggest future revenue growth. The Q&A highlighted optimism for pediatric opportunities and intellectual property strength. Despite some uncertainties in Medicare Part D coverage and IST study timelines, the overall sentiment remains positive with stable gross-to-net dynamics and strategic partnerships. Given the company's small-cap status, these factors are likely to result in a 2% to 8% stock price increase.
ARQT Slides
ARQT Report
Frequently Asked Questions
What is the Arcutis Biotherapeutics Inc {quarter} Earnings Release Date and Time?
Arcutis Biotherapeutics Inc (ARQT) is scheduled to release its {quarter} earnings report on Feb 25, 2026, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Arcutis Biotherapeutics Inc {quarter} Revenue and EPS?
Analysts' consensus predicts 115.71M in revenue and an EPS of 0.03 for Arcutis Biotherapeutics Inc's {quarter}.
What Does Intellectia's AI Predict for Arcutis Biotherapeutics Inc {quarter} Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Arcutis Biotherapeutics Inc's {quarter} earnings, with a prediction date of Feb 25, 2026. Arcutis Biotherapeutics Inc {summary}
How Can I Use This Earnings Prediction to Trade ARQT Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Feb 25, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Arcutis Biotherapeutics Inc {quarter}?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
